Charah Solutions, Inc.
Get $10 bonus on your first $100 deposit for CHRA
Get $10 bonus on your first $100 deposit for CHRA
Charah Solutions, Inc. (CHRA) Stock Competitors & Peer Comparison
See (CHRA) competitors and their performances in Stock Market.
Peer Comparison Table: Waste Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHRA | $5.96 | +0.17% | 20.3M | -0.15 | -$38.80 | N/A |
| WM | $229.45 | -1.57% | 92.5B | 34.20 | $6.71 | +1.49% |
| RSG | $214.66 | -1.08% | 66.3B | 31.37 | $6.84 | +1.15% |
| WCN | $161.59 | -1.35% | 41.3B | 38.75 | $4.17 | +0.82% |
| GFLU | $70.30 | +4.32% | 25B | -91.90 | -$0.77 | N/A |
| CLH | $302.23 | +0.02% | 16.1B | 41.45 | $7.29 | N/A |
| GFL | $43.08 | -3.21% | 14.9B | 107.73 | $0.40 | +0.14% |
| SRCL | $61.98 | +0.83% | 5.8B | 158.92 | $0.39 | N/A |
| CWST | $86.98 | +0.24% | 5.4B | 724.83 | $0.12 | N/A |
| NVRI | $19.56 | -0.36% | 1.6B | -9.64 | -$2.03 | N/A |
Stock Comparison
CHRA vs WM Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WM has a market cap of 92.5B. Regarding current trading prices, CHRA is priced at $5.96, while WM trades at $229.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WM's P/E ratio is 34.20. In terms of profitability, CHRA's ROE is +20.59%, compared to WM's ROE of +0.29%. Regarding short-term risk, CHRA is less volatile compared to WM. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WM's competition here
CHRA vs RSG Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, RSG has a market cap of 66.3B. Regarding current trading prices, CHRA is priced at $5.96, while RSG trades at $214.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas RSG's P/E ratio is 31.37. In terms of profitability, CHRA's ROE is +20.59%, compared to RSG's ROE of +0.18%. Regarding short-term risk, CHRA is less volatile compared to RSG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check RSG's competition here
CHRA vs WCN Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WCN has a market cap of 41.3B. Regarding current trading prices, CHRA is priced at $5.96, while WCN trades at $161.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WCN's P/E ratio is 38.75. In terms of profitability, CHRA's ROE is +20.59%, compared to WCN's ROE of +0.13%. Regarding short-term risk, CHRA is less volatile compared to WCN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WCN's competition here
CHRA vs GFLU Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFLU has a market cap of 25B. Regarding current trading prices, CHRA is priced at $5.96, while GFLU trades at $70.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFLU's P/E ratio is -91.90. In terms of profitability, CHRA's ROE is +20.59%, compared to GFLU's ROE of N/A. Regarding short-term risk, CHRA is less volatile compared to GFLU. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFLU's competition here
CHRA vs CLH Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CLH has a market cap of 16.1B. Regarding current trading prices, CHRA is priced at $5.96, while CLH trades at $302.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CLH's P/E ratio is 41.45. In terms of profitability, CHRA's ROE is +20.59%, compared to CLH's ROE of +0.14%. Regarding short-term risk, CHRA is less volatile compared to CLH. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CLH's competition here
CHRA vs GFL Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFL has a market cap of 14.9B. Regarding current trading prices, CHRA is priced at $5.96, while GFL trades at $43.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFL's P/E ratio is 107.73. In terms of profitability, CHRA's ROE is +20.59%, compared to GFL's ROE of +0.50%. Regarding short-term risk, CHRA is less volatile compared to GFL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFL's competition here
CHRA vs SRCL Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SRCL has a market cap of 5.8B. Regarding current trading prices, CHRA is priced at $5.96, while SRCL trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SRCL's P/E ratio is 158.92. In terms of profitability, CHRA's ROE is +20.59%, compared to SRCL's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to SRCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SRCL's competition here
CHRA vs CWST Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CWST has a market cap of 5.4B. Regarding current trading prices, CHRA is priced at $5.96, while CWST trades at $86.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CWST's P/E ratio is 724.83. In terms of profitability, CHRA's ROE is +20.59%, compared to CWST's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to CWST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CWST's competition here
CHRA vs NVRI Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NVRI has a market cap of 1.6B. Regarding current trading prices, CHRA is priced at $5.96, while NVRI trades at $19.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NVRI's P/E ratio is -9.64. In terms of profitability, CHRA's ROE is +20.59%, compared to NVRI's ROE of -0.49%. Regarding short-term risk, CHRA is less volatile compared to NVRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NVRI's competition here
CHRA vs HCCI Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HCCI has a market cap of 1.1B. Regarding current trading prices, CHRA is priced at $5.96, while HCCI trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HCCI's P/E ratio is 14.22. In terms of profitability, CHRA's ROE is +20.59%, compared to HCCI's ROE of +0.22%. Regarding short-term risk, CHRA is less volatile compared to HCCI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HCCI's competition here
CHRA vs MEG Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, MEG has a market cap of 782.8M. Regarding current trading prices, CHRA is priced at $5.96, while MEG trades at $21.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas MEG's P/E ratio is -155.39. In terms of profitability, CHRA's ROE is +20.59%, compared to MEG's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to MEG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check MEG's competition here
CHRA vs HSC Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HSC has a market cap of 729.6M. Regarding current trading prices, CHRA is priced at $5.96, while HSC trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HSC's P/E ratio is -5.08. In terms of profitability, CHRA's ROE is +20.59%, compared to HSC's ROE of -0.49%. Regarding short-term risk, CHRA is less volatile compared to HSC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HSC's competition here
CHRA vs YDDL Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, YDDL has a market cap of 227.5M. Regarding current trading prices, CHRA is priced at $5.96, while YDDL trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas YDDL's P/E ratio is 34.40. In terms of profitability, CHRA's ROE is +20.59%, compared to YDDL's ROE of +0.36%. Regarding short-term risk, CHRA is less volatile compared to YDDL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check YDDL's competition here
CHRA vs PESI Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, PESI has a market cap of 225.2M. Regarding current trading prices, CHRA is priced at $5.96, while PESI trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas PESI's P/E ratio is -20.93. In terms of profitability, CHRA's ROE is +20.59%, compared to PESI's ROE of -0.25%. Regarding short-term risk, CHRA is less volatile compared to PESI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check PESI's competition here
CHRA vs JAN Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, JAN has a market cap of 207.6M. Regarding current trading prices, CHRA is priced at $5.96, while JAN trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas JAN's P/E ratio is -70.06. In terms of profitability, CHRA's ROE is +20.59%, compared to JAN's ROE of +0.00%. Regarding short-term risk, CHRA is less volatile compared to JAN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check JAN's competition here
CHRA vs ESGL Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ESGL has a market cap of 136.9M. Regarding current trading prices, CHRA is priced at $5.96, while ESGL trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ESGL's P/E ratio is -53.83. In terms of profitability, CHRA's ROE is +20.59%, compared to ESGL's ROE of -0.06%. Regarding short-term risk, CHRA is less volatile compared to ESGL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ESGL's competition here
CHRA vs LNZA Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LNZA has a market cap of 59.7M. Regarding current trading prices, CHRA is priced at $5.96, while LNZA trades at $27.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LNZA's P/E ratio is -1.22. In terms of profitability, CHRA's ROE is +20.59%, compared to LNZA's ROE of +5.56%. Regarding short-term risk, CHRA is less volatile compared to LNZA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LNZA's competition here
CHRA vs LICY Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LICY has a market cap of 29.9M. Regarding current trading prices, CHRA is priced at $5.96, while LICY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LICY's P/E ratio is -0.15. In terms of profitability, CHRA's ROE is +20.59%, compared to LICY's ROE of -0.41%. Regarding short-term risk, CHRA is less volatile compared to LICY. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LICY's competition here
CHRA vs AMBI Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AMBI has a market cap of 24.4M. Regarding current trading prices, CHRA is priced at $5.96, while AMBI trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AMBI's P/E ratio is -44.00. In terms of profitability, CHRA's ROE is +20.59%, compared to AMBI's ROE of -0.02%. Regarding short-term risk, CHRA is less volatile compared to AMBI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AMBI's competition here
CHRA vs QRHC Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, QRHC has a market cap of 23.5M. Regarding current trading prices, CHRA is priced at $5.96, while QRHC trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas QRHC's P/E ratio is -1.53. In terms of profitability, CHRA's ROE is +20.59%, compared to QRHC's ROE of -0.36%. Regarding short-term risk, CHRA is less volatile compared to QRHC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check QRHC's competition here
CHRA vs ENGS Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ENGS has a market cap of 17.4M. Regarding current trading prices, CHRA is priced at $5.96, while ENGS trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ENGS's P/E ratio is -5.52. In terms of profitability, CHRA's ROE is +20.59%, compared to ENGS's ROE of +0.28%. Regarding short-term risk, CHRA is less volatile compared to ENGS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ENGS's competition here
CHRA vs AQMS Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AQMS has a market cap of 12.9M. Regarding current trading prices, CHRA is priced at $5.96, while AQMS trades at $3.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AQMS's P/E ratio is -0.25. In terms of profitability, CHRA's ROE is +20.59%, compared to AQMS's ROE of -2.52%. Regarding short-term risk, CHRA is less volatile compared to AQMS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AQMS's competition here
CHRA vs AWX Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AWX has a market cap of 10.2M. Regarding current trading prices, CHRA is priced at $5.96, while AWX trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AWX's P/E ratio is 32.75. In terms of profitability, CHRA's ROE is +20.59%, compared to AWX's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to AWX. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AWX's competition here
CHRA vs CHNR Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CHNR has a market cap of 4.8M. Regarding current trading prices, CHRA is priced at $5.96, while CHNR trades at $3.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CHNR's P/E ratio is -7.46. In terms of profitability, CHRA's ROE is +20.59%, compared to CHNR's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to CHNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CHNR's competition here
CHRA vs CDTG Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CDTG has a market cap of 4.4M. Regarding current trading prices, CHRA is priced at $5.96, while CDTG trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CDTG's P/E ratio is -2.96. In terms of profitability, CHRA's ROE is +20.59%, compared to CDTG's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to CDTG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CDTG's competition here
CHRA vs GWAV Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GWAV has a market cap of 2.9M. Regarding current trading prices, CHRA is priced at $5.96, while GWAV trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GWAV's P/E ratio is 0.02. In terms of profitability, CHRA's ROE is +20.59%, compared to GWAV's ROE of -0.89%. Regarding short-term risk, CHRA is less volatile compared to GWAV. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GWAV's competition here
CHRA vs DXST Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, DXST has a market cap of 2M. Regarding current trading prices, CHRA is priced at $5.96, while DXST trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas DXST's P/E ratio is -6.06. In terms of profitability, CHRA's ROE is +20.59%, compared to DXST's ROE of -0.04%. Regarding short-term risk, CHRA is less volatile compared to DXST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check DXST's competition here
CHRA vs ECOLW Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOLW has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOLW trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOLW's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOLW's ROE of +0.01%. Regarding short-term risk, CHRA and ECOLW have similar daily volatility (0.00).Check ECOLW's competition here
CHRA vs NES Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NES has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while NES trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NES's P/E ratio is -1.32. In terms of profitability, CHRA's ROE is +20.59%, compared to NES's ROE of -0.29%. Regarding short-term risk, CHRA is less volatile compared to NES. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NES's competition here
CHRA vs CVA Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CVA has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while CVA trades at $20.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CVA's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to CVA's ROE of -0.08%. Regarding short-term risk, CHRA is less volatile compared to CVA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CVA's competition here
CHRA vs ECOL Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOL has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOL trades at $47.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOL's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOL's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to ECOL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ECOL's competition here
CHRA vs SMED Comparison April 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SMED has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while SMED trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SMED's P/E ratio is 36.46. In terms of profitability, CHRA's ROE is +20.59%, compared to SMED's ROE of +0.34%. Regarding short-term risk, CHRA is less volatile compared to SMED. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SMED's competition here